Healthcare & Life Sciences
Werewolf Therapeutics
United Stateswerewolftx.com
Werewolf Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 2 tracked investors.
Activeseries-b
series-b
Stage
2
Investors
About Werewolf Therapeutics
Werewolf Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Werewolf Therapeutics develops conditionally activated immunotherapies that selectively stimulate the immune system within the tumor microenvironment to treat cancer while minimizing off-target effects.
Explore Werewolf Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.